Company name
2022Founder
David Grangier is a machine learning researcher at Genesis Molecular AI, where he works on applying machine learning to drug discovery. His research has spanned language modeling, neural machine translation, and other large-scale machine learning methods, including work on convolutional language models and sequence-to-sequence learning.
Machine Learning Researcher